How ChatGPT Enterprise Changed Moderna's Use

Tell me about your internal AI chatbot tool, mChat.

So, we have a principle here, which is to be the masters of our own technology. Of course, we use tools from vendors, we use tools from cloud providers, we use tools from Office Suite, you know, and productivity suites that we didn't design, and it would be crazy to redesign them this huge investments. But in the field of AI, we created our own ML platform, which is called compute. And we're now the fourth version of it. And so, we don't leverage another technology providers machine learning platform, it is the one that we built a decade ago, it is quite essential to who we are as a company, because we never sell them a platform to define the appropriate mRNA to meet a protein. And so, it is one of our core assets. And because we have such a strong ml Foundation, Mchat is the agent that works on top of that ML foundation to give us the benefits of generative AI one step or two steps ahead with things that are not available in the market. So, when we launched M chat a year ago, it was a customer client to the model of open AI at the time to GBT four. And we would just use the API to that model to this client to make it available to everyone. At that time before GBG enterprise was available. That was the best we could come up with our own engineering. But then, GBT launched and as you know, we have a partnership with open AI on leveraging it at Moderna. And so, the key question for us is, what is the next thing that we don't have, that we can buy off the shelf, and that we need to build process.

And so, Mchat is evolving right now into a stateless technology in which you don't keep records of conversations or documents. But it's plugged into our databases, and as a Chrome extension. And so, in any of our corporate tools, we can leverage the power of AI in the context of work, plugged into the data that we work with directly from the source without having to upload or refreshing document. And this is not yet something that is provided by the market but maybe that at some point, either Microsoft or open AI will come up with a product like this, but in the meantime, we have a chat to the second iteration, as a Chrome extension, that gives us the capability to interact with the conversation interface with any type of data that we have, through the software, and the applications that are available to us professionally, on our laptops, and especially in the SAS environment of our web browser. So, Mchat is a very moving target, because it has been very different things. But there's one common principle that I want to highlight here. M chat always case for the book will be it is the way that we design internally, what we believe is the next stage of the evolution of the technology, to get used to it, to learn how to make it a part of our work in our life, for the woman going to become a table stake, and that it will be provided. And then in chapter three, will be the next generation of AI agents. And at that point, we'll be having another conversation.

How did the launch of ChatGPT Enterprise change things for Moderna?

The launch of ChatGPT Enterprise Mode now keeps us innovative. It keeps us at the forefront of change. We pride ourselves in being research driven people research driven company and exploring new frontiers in research. How do we not try to embrace this new tool that is provided to us and see what can happen with it, and it defines us. And so, we find not only that it helps us with human augmentation, being more productive, being more innovative being more collaborative, having, you know, a way for personal growth, through the presence of conversation with agents is also a find an anchor of our identity as a company, modernize the first mover came first with the with the vaccine for COVID. And I'm not going to argue the differentials of the various companies. But when was in the frontline of dealing with the disease when it appeared and finding a solution? And the reason for this, of course, is that every moment we gain is life that are saved. And so, we want to stay first. We want to be always leading the fight against the disease, against cancer against viruses against rare diseases.

So, the fact that we are leading with the latest tools that we embrace them at scale, and that we are the first to do it, but open air recognizes us for it. But we recognize ourselves for it. It not only brings all the goodness of the tool, it's also a cultural anchor of who we are, it defines us. And I think this might be unique to Madonna, but I would also call for anyone hearing this to yourself how you're going to react to technology disruption, because this is who you are, it defines us like we can lead the change and embrace it and actually be an actor of change. You can like change and be a festival or of change. You can go with the flow. And if the industry moves, then you move within she doesn't move then you don't move. You can dislike change and have a grudge with it. And keep saying yeah, right. But look at it he does monkey tricks he speaks like a pirate is it really a good solution for the future of pharmacy, or you could fight teach, you can be you know, our identities to fight AI, we will fight it to the to the tooth and nail you know, over my dead body. And these five flavors of who we are as individuals and organizations in the face of radical change. We fight for it. We like it. We go with the flow. We don't like it. We fight against it. They define us. And I believe that here we define ourselves when we fight for change.